BiosanaPharma

About BiosanaPharma

BiosanaPharma has developed a highly flexible, comprehensive Continuous Manufacturing (CM) automation platform, suitable for all relevant GMP production scales (50L, 500L, and 2000L). Our 3C platform is unit operation-independent, and with integrated automatic sampling and on/at-line analytical, a continuous downstream process (DSP) can be fully implemented within 12 to 18 months.”

Keywords

• Biosimilar Mabs
• Biotechnology
• Low Cost Of Goods
• Monoclonal Antibodies

Address

• Headquarters

  J.H. Oortweg2333CH LeidenZuid-Holland, Netherlands

Team by function

Based on 2 public job profiles as of 3 September 2026.

• Data / Analytics / Science1
• Executive / C-Suite1